Friday, January 11, 2013- Is Teva Just Looking Out for Itselfat Motley Fool (Fri, Jan 11)
- The Flu Shot's Not A Great Vaccine, But You Should Get One Anywayat Forbes (Fri, Jan 11)
- Bayer to Buy ProphytaZacks (Fri, Jan 11)
- Lilly to Go Solo with LY2605541Zacks (Fri, Jan 11)
- Can This Biotech Wow Wall Street?at Motley Fool (Fri, Jan 11)
- Don't Lose Sight Of Cooper Companiesat Seeking Alpha (Fri, Jan 11)
- Phase 3 Data Backs Novartis' Afinitorat Motley Fool (Fri, Jan 11)
- Infinity Provides Pipeline UpdateZacks (Fri, Jan 11)
- The Biggest Week in Health Careat Motley Fool (Fri, Jan 11)
- Puerto Rican company picks Garner for distribution centerat bizjournals.com (Fri, Jan 11)
- Novartis AG Stock Buy Recommendation Reiterated (NVS)at TheStreet (Fri, Jan 11)
- The Zacks Analyst Blog Highlights: GlaxoSmithKline, Theravance, Merck, Sanofi and NovartisZacks (Fri, Jan 11)
Thursday, January 10, 2013 Wednesday, January 9, 2013 Tuesday, January 8, 2013Add NVS News to My Yahoo!  | |
|